RCM
BIOA

RA Capital Management’s BioAge Labs BIOA Stock Holding History

RA Capital Management’s Portfolio BIOA Stock Details BIOA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$41M Buy
1,671,648
+21,000
+1% +$379K 0.36% 45
2026
Q1 		$28.9M Buy
+1,650,648
New +$31.8M 0.31% 46
2025
Q2 		– Sell
-1,052,494
Closed -$3.96M – 89
2025
Q1 		$3.96M Sell
1,052,494
-258,095
-20% -$1.19M 0.07% 79
2024
Q4 		$7.59M Sell
1,310,589
-900,000
-41% -$15.5M 0.1% 78
2024
Q3 		$46M Buy
+2,210,589
New +$44.3M 0.53% 39

Other funds holding BIOA

ACM
AH Capital Management Menlo Park, California $14.2B AUM 20.01% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
OCA
Octagon Capital Advisors New York $1.11B AUM 866.76% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.64B AUM 245.64% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PCH
Polar Capital Holdings London, United Kingdom $42.4B AUM 181.11% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return

RA Capital Management's BIOA Position: Q2 2026 in Review

RA Capital Management increased its BioAge Labs (BIOA) stake by 1.3% in Q2 2026, buying an estimated $379K and bringing the position to 1,671,648 shares worth $41M. The position accounts for 0.36% of the portfolio, ranked #45.

RA Capital Management first reported a position in BIOA in Q3 2024 and has held it in 5 quarters since. The position peaked at $46M in Q3 2024. 150 funds tracked by Wall St. Rank hold BIOA as of Q2 2026.

  • RA Capital Management held 1,671,648 shares of BioAge Labs worth $41M as of Q2 2026.
  • RA Capital Management bought 21,000 BioAge Labs shares in Q2 2026, an estimated $379K.
  • BioAge Labs made up 0.36% of RA Capital Management's portfolio in Q2 2026, its #45 holding.
  • RA Capital Management first reported a position in BioAge Labs in Q3 2024 and has held it in 5 quarters since.
  • RA Capital Management's BioAge Labs position peaked at $46M in Q3 2024.
  • 150 funds tracked by Wall St. Rank held BioAge Labs as of Q2 2026.

Based on RA Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.